S&P 500 (SPY) $729.46 -1.54%Nasdaq 100 (QQQ) $661.73 -2.04%Dow Jones (DIA) $515.41 -2.18%Russell 2000 (IWM) $288.57 -1.64%Gold (GLD) $371.08 +0.46%10Y Bond (TLT) $82.85 -1.65% S&P 500 (SPY) $729.46 -1.54%Nasdaq 100 (QQQ) $661.73 -2.04%Dow Jones (DIA) $515.41 -2.18%Russell 2000 (IWM) $288.57 -1.64%Gold (GLD) $371.08 +0.46%10Y Bond (TLT) $82.85 -1.65%
Earnings June 4, 2026 at 7:00 AM

Cognyte Software Ltd Earnings: Miss on EPS and Revenue

Cognyte Software Ltd (CGNT) reported earnings that fell short of analyst expectations on June 3, 2026, with earnings per share of $0.03 missing the consensus estimate of $0.09 by $0.06.

The company delivered a significant EPS miss of 65.28%, representing a substantial shortfall from Wall Street projections of $0.09 per share. The actual EPS of $0.03 marked a disappointing performance for the quarter.

Revenue for the period totaled $105.49 million, falling short of the estimated $107.26 million by $1.77 million. This represented a revenue miss of 1.65%, bringing in approximately $105.49 million versus expectations of $107.26 million.

About Cognyte Software

Cognyte is an Israeli-headquartered security analytics software vendor that spun off from Verint Systems in February 2021. The company sells investigative analytics platforms to enterprise and government customers, focused on three primary verticals: national security and law enforcement, financial institutions (anti-money-laundering and fraud detection), and customer engagement / operational intelligence. Its flagship product line, Cybereason-adjacent tooling aside, centers on the Investigative Case Management and Phonetic Indexing platforms inherited from the Verint security business.

Cognyte competes in a fragmented market against larger players such as Palantir Technologies (in the national-security segment), NICE Actimize (financial compliance), and smaller specialists like Exabeam and Dataminr. Its positioning is mid-market — too small to compete head-to-head with Palantir on multi-billion-dollar defense contracts, but more focused than broad-line analytics vendors like Splunk (now Cisco) or Elastic.

Quarter Context

Cognyte operates on a fiscal year ending January 31, so the period reported in early June 2026 corresponds to fiscal Q1 2027. The dual miss on EPS and revenue follows a multi-year trend of declining topline: revenue has compressed from roughly $474 million in fiscal 2022 (pre-spinoff run-rate) toward the low-$100M-per-quarter zone, as the company has divested non-core operations and customers in Western Europe and North America have consolidated security tooling spend onto fewer platforms.

The EPS miss of 65% is partially explained by margin compression: Cognyte’s non-GAAP gross margin has held in the 65-68% range, but operating expenses — particularly R&D headcount in Israel and sales engineering in the Americas — have not scaled down proportionally with revenue, leaving operating margins thin and amplifying the impact of small revenue shortfalls on bottom-line EPS.

Customer and Geographic Mix

Cognyte derives a significant share of revenue from long-term, multi-year enterprise contracts, which provides revenue visibility but also means that any single quarter’s bookings can materially shift out-year assumptions. Geographic exposure is concentrated in North America (roughly 45-50% of revenue), EMEA (around 30%), and the rest of the world — including APAC and Latin America — accounting for the balance.

The company has been working to grow its recurring revenue mix (software subscription and maintenance as a percentage of total) and reduce dependence on perpetual licenses, a transition that has been a multi-year headwind on reported revenue even as gross profit dollars have remained roughly stable.

Forward-Looking Considerations

Management commentary in prior quarters has emphasized three priorities: (1) stabilizing revenue in EMEA following several large-customer renewals coming up for bid in calendar 2026, (2) accelerating cross-sell of the Phonetic Indexing product line into existing national-security accounts, and (3) cost discipline, particularly around R&D vendor spend and real-estate consolidation in Israel.

Analyst consensus for the next reporting period (fiscal Q2 2027, reported in early September 2026) was approximately $0.07 EPS on $108 million of revenue prior to this print. After the miss, sell-side estimates are likely to be revised lower, with the magnitude depending on whether management guides to a sequential recovery or signals continued headwinds. Investors should monitor the next earnings call for updated annual guidance and commentary on EMEA renewal activity.

This article is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results. Forward-looking statements are subject to risks and uncertainties; actual results may differ materially.